The activation peptide of coagulation factor XIII is vital for its expression and stability

Muszbek, 2011, Factor XIII: a coagulation factor with multiple plasmatic and cellular functions, Physiol Rev, 91, 931, 10.1152/physrev.00016.2010 Schroeder, 2013, New developments in the area of factor XIII, J Thromb Haemost, 11, 234, 10.1111/jth.12074 Richardson, 2013, Substrates of factor XIII‐A: roles in thrombosis and wound healing, Clin Sci (Lond), 124, 123, 10.1042/CS20120233 Hornyak, 1991, Role of calcium ion in the generation of factor XIII activity, Biochemistry, 30, 6175, 10.1021/bi00239a014 Yee, 1995, Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII, Thromb Res, 78, 389, 10.1016/0049-3848(95)00072-Y Ortner, 2010, Sensitive and selective detection of free FXIII activation peptide: a potential marker of acute thrombotic events, Blood, 115, 5089, 10.1182/blood-2009-11-253062 Kristiansen, 2011, Reversible activation of cellular factor XIII by calcium, J Biol Chem, 286, 9833, 10.1074/jbc.M110.174128 Polgar, 1990, Non‐proteolytic activation of cellular protransglutaminase (placenta macrophage factor XIII), Biochem J, 267, 557, 10.1042/bj2670557 Komaromi, 2011, Factor XIII: novel structural and functional aspects, J Thromb Haemost, 9, 9, 10.1111/j.1538-7836.2010.04070.x Weiss, 1998, Two non‐proline cis peptide bonds may be important for factor XIII function, FEBS Lett, 423, 291, 10.1016/S0014-5793(98)00098-2 Sadasivan, 2000, Interaction of the factor XIII activation peptide with alpha‐thrombin. Crystal structure of its enzyme–substrate analog complex, J Biol Chem, 275, 36942, 10.1074/jbc.M006076200 Balogh, 2000, Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia, Blood, 96, 2479, 10.1182/blood.V96.7.2479.h8002479_2479_2486 Kohler, 1998, A common coding polymorphism in the FXIII A‐subunit gene (FXIIIVal34Leu) affects cross‐linking activity, Thromb Haemost, 80, 704 Ariens, 2000, The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross‐linked fibrin structure, Blood, 96, 988, 10.1182/blood.V96.3.988 Schroeder, 2001, Influence of blood coagulation factor XIII and FXIII Val34Leu on plasma clot formation measured by thrombelastography, Thromb Res, 104, 467, 10.1016/S0049-3848(01)00395-4 Johansson, 2011, Activation peptides prolong the murine plasma half‐life of human factor VII, Blood, 117, 3445, 10.1182/blood-2010-06-290098 Ariens, 1999, Subunit antigen and activity levels of blood coagulation factor XIII in healthy individuals. Relation to sex, age, smoking, and hypertension, Arterioscler Thromb Vasc Biol, 19, 2012, 10.1161/01.ATV.19.8.2012 Tsunasawa, 1985, Amino‐terminal processing of mutant forms of yeast iso‐1‐cytochrome c. The specificities of methionine aminopeptidase and acetyltransferase, J Biol Chem, 260, 5382, 10.1016/S0021-9258(18)89033-0 Sherman, 1985, Methionine or not methionine at the beginning of a protein, BioEssays, 3, 27, 10.1002/bies.950030108 Polevoda, 2003, N‐terminal acetyltransferases and sequence requirements for N‐terminal acetylation of eukaryotic proteins, J Mol Biol, 325, 595, 10.1016/S0022-2836(02)01269-X Bachmair, 1986, In vivo half‐life of a protein is a function of its amino‐terminal residue, Science, 234, 179, 10.1126/science.3018930 Varshavsky, 2011, The N‐end rule pathway and regulation by proteolysis, Protein Sci, 20, 1298, 10.1002/pro.666 Krissinel, 2011, Macromolecular complexes in crystals and solutions, Acta Crystallogr D Biol Crystallogr, 67, 376, 10.1107/S0907444911007232 Dong, 1997, Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solution, Arch Biochem Biophys, 347, 213, 10.1006/abbi.1997.0349 Kurochkin, 1995, Domain structure, stability and domain–domain interactions in recombinant factor XIII, J Mol Biol, 248, 414, 10.1016/S0022-2836(95)80060-3 Takahashi, 1986, Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta, Proc Natl Acad Sci USA, 83, 8019, 10.1073/pnas.83.21.8019 Cariello, 1997, A new transglutaminase‐like from the ascidian Ciona intestinalis, FEBS Lett, 408, 171, 10.1016/S0014-5793(97)00342-6 Yeh, 2006, Biochemical characterization and cloning of transglutaminases responsible for hemolymph clotting in Penaeus monodon and Marsupenaeus japonicus, Biochim Biophys Acta, 1764, 1167, 10.1016/j.bbapap.2006.04.005 Lin, 2008, Transglutaminase activity in the hematopoietic tissue of a crustacean, Pacifastacus leniusculus, importance in hemocyte homeostasis, BMC Immunol, 9, 58, 10.1186/1471-2172-9-58 Meinnel, 2005, Processed N‐termini of mature proteins in higher eukaryotes and their major contribution to dynamic proteomics, Biochimie, 87, 701, 10.1016/j.biochi.2005.03.011 Yurimoto, 2004, The pro‐peptide of Streptomyces mobaraensis transglutaminase functions in cis and in trans to mediate efficient secretion of active enzyme from methylotrophic yeasts, Biosci Biotechnol Biochem, 68, 2058, 10.1271/bbb.68.2058 Shanbhag, 2011, Mutations in coagulation factor XIII subunit A in severe factor XIII deficiency patients: five novel mutations detected, Haemophilia, 17, e843 Mikkola, 1994, Deficiency in the A‐subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels, Blood, 84, 517, 10.1182/blood.V84.2.517.517 Mikkola, 1996, Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A‐subunit, Blood, 87, 141, 10.1182/blood.V87.1.141.141 Handrkova, 2015, Identification of two novel missense mutations causing severe factor XIII deficiency, Haemophilia, 21, e253, 10.1111/hae.12663 Kanchan, 2013, Identification of a specific one amino acid change in recombinant human transglutaminase 2 that regulates its activity and calcium sensitivity, Biochem J, 455, 261, 10.1042/BJ20130696 Bergamini, 1999, Conformational stability of human erythrocyte transglutaminase. Patterns of thermal unfolding at acid and alkaline pH, Eur J Biochem, 266, 575, 10.1046/j.1432-1327.1999.00900.x Wu, 2008, Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa, J Biol Chem, 283, 18655, 10.1074/jbc.M802275200